8-Bromo-1,6-naphthyridin-5(6H)-one, 95.0%, 250mg

Hexahydro-pyrrolo[1,2-a]pyrazin-6-one, 95.0%, 1g

4,4,5,5-Tetramethyl-2-(6-methylcyclohex-1-en-1-yl)-1,3,2-dioxaborolane, 98%, 250mg

(3-Aminophenyl)dimethylphosphine oxide, 97%, 250mg

3,4-Difluoro-4'-(trans-4-propylcyclohexyl)biphenyl>98.0%(GC)5g

1-(4-Bromobutoxy)-2-methoxy-benzene, 98.0%, 25g

z-glu-otbu, 97.0%, 25g

2-[(dimethylcarbamothioyl)sulfanyl]acetonitrile, 95%, 100mg

(S)-3-(3-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 5g

Caffeic acid, min. 98%, 5 g, glass packaging

tert-butyl rac-(3S,4R)-3-amino-4-hydroxy-1-pyrrolidinecarboxylate, 95.0%, 500mg

(2S,4S)-4-tert-Butoxy-1-isopropyl-proline, 97.0%, 1g

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile, 97%, 1g